Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>In this section: The FDA unveils new adverse events dashboard tool, announces intent to hasten generic drug approvals, greenlights a generic drug to treat multiple sclerosis, greenlights biosimilar to treat multiple types of cancers, gives go ahead to leukemia treatment, and approves updated herpes zoster vaccine.</p>

FDA Actions